These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26311504)

  • 1. Advances in radionuclide imaging of cardiac sarcoidosis.
    Kouranos V; Wells AU; Sharma R; Underwood SR; Wechalekar K
    Br Med Bull; 2015 Sep; 115(1):151-63. PubMed ID: 26311504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT Evaluation of Cardiac Sarcoidosis.
    Bois JP; Muser D; Chareonthaitawee P
    PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC; Arrighi JA
    J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
    [No Abstract]   [Full Text] [Related]  

  • 4. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of follow-up gallium single-photon emission computed tomography and fluorine-18-fluorodeoxyglucose positron emission tomography to predict the deterioration of a patient with cardiac sarcoidosis.
    Kaku B; Kanaya H; Horita Y; Uno Y; Yamazaki T; Fujita T; Ohka T
    Circ J; 2004 Aug; 68(8):802-5. PubMed ID: 15277743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
    Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
    Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
    Isiguzo M; Brunken R; Tchou P; Xu M; Culver DA
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):50-5. PubMed ID: 21796891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
    Matoh F; Satoh H; Shiraki K; Odagiri K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Cardiol; 2008 Jun; 51(3):179-88. PubMed ID: 18522793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis].
    Ishida Y; Nakatani S; Tachibana T
    J Cardiol; 2000 Apr; 35(4):301-4. PubMed ID: 10791274
    [No Abstract]   [Full Text] [Related]  

  • 10. Radionuclide Assessment of Sarcoidosis.
    Divakaran S
    Cardiol Clin; 2023 May; 41(2):207-215. PubMed ID: 37003678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced imaging of cardiac sarcoidosis.
    Schatka I; Bengel FM
    J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
    Ohira H; Tsujino I; Yoshinaga K
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
    Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis].
    Okumura W; Iwasaki T; Ueda T; Seki R; Miyajima A; Hatori T; Sato H; Toyama T; Suzuki T; Matsubara K; Otake H; Aoyagi K; Inoue T; Endo K; Nagai R
    Kaku Igaku; 1999 May; 36(4):341-8. PubMed ID: 10390957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
    Campisi R; Merani MF; Rodríguez MI
    Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.
    Youssef G; Leung E; Mylonas I; Nery P; Williams K; Wisenberg G; Gulenchyn KY; Dekemp RA; Dasilva J; Birnie D; Wells GA; Beanlands RS
    J Nucl Med; 2012 Feb; 53(2):241-8. PubMed ID: 22228794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
    Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.
    Ohira H; Tsujino I; Sato T; Yoshinaga K; Manabe O; Oyama N; Nishimura M
    Intern Med; 2011; 50(11):1207-9. PubMed ID: 21628936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.